Impact of extent of resection on overall survival in newly-diagnosed glioblastoma after chemo-irradiation with temozolomide: further analysis of EORTC study 26981

被引：0
|
作者：
van den Bent, M. J.
Stupp, R.
Mason, W.
Mirimanoff, R. O.
Lacombe, D.
Gorlia, T.
机构：
[1] Daniel Hoed Canc Ctr, Rotterdam, Netherlands
[2] CHU Vaudois, Lausanne, Switzerland
[3] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[4] Eortc Data Ctr, Brussels, Belgium
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 30 条
  • [1] The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study
    Lau, Arthur C. K.
    Chan, Brandon L. H.
    Yeung, Carly S. K.
    Li, Lai-Fung
    Chan, Danny T. M.
    Lee, Michael W. Y.
    Chan, Tony K. T.
    Ho, Jason M. K.
    Cheung, Ka-Man
    Tse, Teresa P. K.
    Lau, Sarah S. N.
    Chow, Joyce S. W.
    Ko, Natalie M. W.
    Loong, Herbert H. F.
    El-Helali, Aya
    Poon, Wai-Sang
    Woo, Peter Y. M.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [2] Quality assurance of the EORTC 26981/22981; NCICCE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review
    Ataman, F
    Poortmans, P
    Stupp, R
    Fisher, B
    Mirimanoff, RO
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (11) : 1724 - 1730
  • [3] INTEGRATING MOLECULAR MARKERS AND EXTENT OF RESECTION FOR RISK STRATIFICATION OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: A MULTICENTRE STUDY
    Sayeed, Wajid
    Batuyong, Eugene
    Li, Haocheng
    Cadieux, Magalie
    Kelly, John
    Scott, James
    Semenchuk, Julie
    Pitz, Marshall
    Easaw, Jacob
    NEURO-ONCOLOGY, 2016, 18 : 194 - 194
  • [4] Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
    Sotirios Katsigiannis
    Boris Krischek
    Stefanie Barleanu
    Stefan Grau
    Norbert Galldiks
    Marco Timmer
    Christoph Kabbasch
    Roland Goldbrunner
    Pantelis Stavrinou
    Radiation Oncology, 14
  • [5] Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
    Katsigiannis, Sotirios
    Krischek, Boris
    Barleanu, Stefanie
    Grau, Stefan
    Galldiks, Norbert
    Timmer, Marco
    Kabbasch, Christoph
    Goldbrunner, Roland
    Stavrinou, Pantelis
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [6] Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
    Sun, Matthew Z.
    Oh, Taemin
    Ivan, Michael E.
    Clark, Aaron J.
    Safaee, Michael
    Sayegh, Eli T.
    Kaur, Gurvinder
    Parsa, Andrew T.
    Bloch, Orin
    JOURNAL OF NEUROSURGERY, 2015, 122 (05) : 1144 - 1150
  • [7] Impact of extent of resection of newly diagnosed glioblastomas on survival: a meta-analysis
    AbdelFatah, Mohamed A. R.
    Kotb, Ali
    Said, Mohamed Ahmed
    Abouelmaaty, Emad M. H.
    EGYPTIAN JOURNAL OF NEUROSURGERY, 2022, 37 (01)
  • [8] Impact of extent of resection of newly diagnosed glioblastomas on survival: a meta-analysis
    Mohamed A. R. AbdelFatah
    Ali Kotb
    Mohamed Ahmed Said
    Emad M. H. Abouelmaaty
    Egyptian Journal of Neurosurgery, 37
  • [9] Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
    Mirimanoff, RO
    Gorlia, T
    Mason, W
    Van den Bent, MJ
    Kortman, RD
    Fisher, B
    Reni, M
    Brandes, AA
    Curschmann, J
    Villa, S
    Cairncross, G
    Allgeier, A
    Lacombe, D
    Stupp, R
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) : 2563 - 2569
  • [10] Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
    Gorlia, Thierry
    van den Bent, Martini
    Hegi, Monika E.
    Mirimanoff, Rene O.
    Weller, Michael
    Cairncross, J. Gregory
    Eisenhauer, Elizabeth
    Belanger, Karl
    Brandes, Alba A.
    Allgeier, Anouk
    Lacombe, Denis
    Stupp, Roger
    LANCET ONCOLOGY, 2008, 9 (01): : 29 - 38
123